Skip to main content
. 2022 Jan 19;162(1):76–81. doi: 10.1016/j.chest.2022.01.015

Figure 1.

Figure 1

For 26 patients, detailed treatment information was available. Treatment during the intensive phase and the continuation phase are specified and include antibiotic regimens. Breaks in the regimen are of unspecified length. IV antibiotics consisted of amikacin, cefoxitin, imipenem, meropenem, and tigecycline. Oral antibiotics consisted of azithromycin, bedaquiline, clarithromycin, clofazimine, doxycycline, linezolid, minocycline, moxifloxacin, and rifamycin. Inhaled antibiotics consisted of amikacin inhalation (not ALIS), liposomal amikacin inhalation. Treatment either ended or was still ongoing. ALIS = liposomal amikacin inhalation; Am = amikacin; Amin = amikacin inhalation (not ALIS); Az = azithromycin; Be = bedaquiline; Ce = cefoxitin; Cl = clofazimine; Cla = clarithromycin; Do = doxycycline; Im = imipenem; Li = linezolid; Me = meropenem; Mino = minocycline; Mo = moxifloxacin; Ri = rifamycin; Ti = tigecycline.